https://www.selleckchem.com/pr....oducts/AZD2281(Olapa
32%) did not qualitatively pre-test their DCE, and a majority did not report the uncertainty in estimated outcomes (n=18; 64%). DCEs in asthma and COPD have focused on treatment benefits and convenience, with less evidence generated on participants' risk tolerance. Quality criteria and reporting standards are needed to promote study quality and ensure consistency in reporting between studies. DCEs in asthma and COPD have focused on treatment benefits and convenience, with less evidence generated on participants' risk tolerance
Like
Comment
Share
